Cited by 557Multiple Sclerosis Research StudiesPsoriasis: Treatment and PathogenesisT-cell and B-cell Immunology

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Preferential recruitment of interferon‐γ–expressing T H 17 cells in multiple sclerosis

Kebir, Hania, Ifergan, Igal, Alvarez, Jorge Ivan, Bernard, Monique, Poirier, Josée, Arbour, Nathalie, Duquette, Pierre, Prat, Alexandre·2009·Annals of Neurology

DOI 10.1002/ana.21748

Open this paper in CoChat — free account

Abstract

Objective: There is substantial evidence supporting the role of interferon (IFN)‐γ–producing T helper (T H ) 1 and interleukin (IL)‐17–expressing T H 17 lymphocytes in multiple sclerosis (MS) and its animal model, experimental allergic encephalomyelitis (EAE). However, to date little is known about the potential cooperative interplay between these 2 cytokines. In the current study, we sought to evaluate the frequency of IFN‐γ–expressing T H 17 lymphocytes in MS and EAE, and study their recruitment into the central nervous system (CNS). Methods: Human T H 17 lymphocytes were expanded in vitro from the blood of healthy controls and relapsing MS patients using IL‐23. Immune cell migration to the CNS was assessed in vitro with primary cultures of human blood–brain barrier (BBB)‐derived endothelial cells, and in vivo in EAE mice. Results: We demonstrate that in response to IL‐23, human memory lymphocytes expand into a T H 17 phenotype, with a subpopulation of cells simultaneously expressing IFN‐γ and IL‐17. We note that lymphocytes obtained from the blood of relapsing MS patients have an increased propensity to expand into IFN‐γ–producing T H 17 cells and identify numerous T lymphocytes coexpressing IL‐17 and IFN‐γ in brain tissue of MS patients. We also find lymphocytes expressing both the T H 1‐ and the T H 17‐associated transcription factors RORγt and T‐bet, in situ and in vitro. We further provide in vitro and in vivo evidence that IFN‐γ + T H 17 lymphocytes preferentially cross the human BBB and accumulate in the CNS of mice during the effector phase of EAE. Interpretation: Our data underscore the involvement of IFN‐γ + T H 17 lymphocytes in the pathology of MS and EAE and their preferential recruitment into the CNS during inflammatory events. Ann Neurol 2009;66:390–402

Integrity signals

Registry

Crossref · 10.1002/ana.21748

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Self-citation

Flagged first, then by citations

Show all 39 references

Sorted by citations

Items 101–200 of 557

IL-1–induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation
Lin, C., Bradstreet, T. R., Schwarzkopf, E. A., Jarjour, N. N., Chou, C., Archambault, A. S., Sim, J. E., Zinselmeyer, B. H., Carrero, J. A., Wu, G. F., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20150568 · Cited by 102
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation
Kuijk, L. M., Klaver, E. J., Kooij, G., van der Pol, S. M. A., Heijnen, P. D. A. M., Bruijns, S. C. M., Kringel, H., Pinelli, E., Kraal, G., de Vries, H. E., et al. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.03.020 · Cited by 108
Is Multiple Sclerosis an Autoimmune Disease?
Wootla, B., Eriguchi, M., & Rodriguez, M. (2012) · Autoimmune Diseases · doi:10.1155/2012/969657 · Cited by 105
Dual role of ALCAM in neuroinflammation and blood–brain barrier homeostasis
Lécuyer, M., Saint‐Laurent, O., Bourbonnière, L., Larouche, S., Larochelle, C., Michel, L., Charabati, M., Abadier, M., Zandee, S., Jahromi, N. H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614336114 · Cited by 107
Self-citation
The CD4-centered universe of human T cell subsets
Geginat, J., Paroni, M., Facciotti, F., Gruarin, P., Kastirr, I., Caprioli, F., Pagani, M., & Abrignani, S. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.012 · Cited by 112
Novel CSF biomarkers for frontotemporal lobar degenerations
Hu, W. T., Chen‐Plotkin, A. S., Grossman, M., Arnold, S. E., Clark, C. M., Shaw, L. M. J., McCluskey, L. F., Elman, L., Hurtig, H. I., Siderowf, A. D., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e318200d78d · Cited by 101
Epigallocatechin-3-Gallate Ameliorates Experimental Autoimmune Encephalomyelitis by Altering Balance among CD4+ T-Cell Subsets
Wang, J., Ren, Z., Xu, Y., Xiao, S., Meydani, S. N., & Wu, D. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.007 · Cited by 103
Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease
Shimizu, J., Takai, K., Fujiwara, N., Arimitsu, N. N., Ueda, Y., Wakisaka, S., Yoshikawa, H., Kaneko, F., Suzuki, T., & Suzuki, N. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04543.x · Cited by 101
Peroxisome proliferator–activated receptor δ limits the expansion of pathogenic Th cells during central nervous system autoimmunity
Dunn, S. E., Bhat, R., Straus, D. S., Sobel, R. A., Axtell, R. C., Johnson, A., Nguyen, K., Mukundan, L., Moshkova, M., Dugas, J. C., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091663 · Cited by 99
Role of toll-like receptors in multiple sclerosis.
Miranda‐Hernandez, S., & Baxter, A. G. (2013) · Europe PMC (PubMed Central) · Cited by 96
IL‐9 is important for T‐cell activation and differentiation in autoimmune inflammation of the central nervous system
Li, H., Nourbakhsh, B., Cullimore, M. L., Zhang, G., & Rostami, A. M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041125 · Cited by 102
Immunophenotyping in pemphigus reveals a TH17/TFH17 cell–dominated immune response promoting desmoglein1/3-specific autoantibody production
Holstein, J., Solimani, F., Baum, C., Meier, K., Pollmann, R., Didona, D., Tekath, T., Dugas, M., Casadei, N., Hudemann, C., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.11.008 · Cited by 112
Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis
Ge, Z., Da, Y., Xue, Z., Zhang, K., Zhuang, H., Peng, M., Li, Y., Li, W., Simard, A. R., Hao, J., et al. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.12.006 · Cited by 99
A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis
Ostkamp, P., Deffner, M., Schulte‐Mecklenbeck, A., Wünsch, C., Lu, I., Wu, G. F., Goelz, S. E., Jager, P. L. D., Kuhlmann, T., Groß, C. C., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.adc9778 · Cited by 93
Th17 cells in central nervous system autoimmunity
Sie, C., Korn, T., & Mitsdoerffer, M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.03.009 · Cited by 95
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
Rolla, S., Bardina, V., Mercanti, S. F. D., Quaglino, P., Palma, R. D., Gned, D., Brusa, D., Durelli, L., Novelli, F., & Clerico, M. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0813-463rr · Cited by 90
T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model
Slyepchenko, A., Maes, M., Köhler, C. A., Anderson, G., Quevedo, J., Alves, G. S., Berk, M., Fernandes, B. S., & Carvalho, A. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.002 · Cited by 89
Interferon gamma in autoimmunity: A complicated player on a complex stage
Lees, J. R. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.014 · Cited by 90
Intercellular Adhesion Molecule-1 (ICAM-1) and ICAM-2 Differentially Contribute to Peripheral Activation and CNS Entry of Autoaggressive Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
Jahromi, N. H., Marchetti, L., Moalli, F., Duc, D., Basso, C., Tardent, H., Kaba, E., Deutsch, U., Pot, C., Sallusto, F., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03056 · Cited by 93
Human T helper type 1 dichotomy: origin, phenotype and biological activities
Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., & Romagnani, S. (2014) · Immunology · doi:10.1111/imm.12399 · Cited by 91
Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis
Kleiter, I., Song, J., Lukas, D., Hasan, M., Neumann, B. H., Croxford, A. L., Pedré, X., Hövelmeyer, N., Yogev, N., Mildner, A., et al. (2010) · Brain · doi:10.1093/brain/awq039 · Cited by 88
Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis
Mexhitaj, I., Nyirenda, M. H., Li, R., O’Mahony, J., Rezk, A., Rozenberg, A., Moore, C. S., Johnson, T., Sadovnick, A. D., Collins, D. L., et al. (2019) · Brain · doi:10.1093/brain/awz017 · Cited by 95
Autoimmune Memory T Helper 17 Cell Function and Expansion Are Dependent on Interleukin-23
Haines, C. J., Chen, Y., Blumenschein, W. M., JAIN, R. K., Chang, C., Joyce-Shaikh, B., Porth, K., Boniface, K., Mattson, J. D., Basham, B., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.035 · Cited by 87
Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis
Veroni, C., Serafini, B., Rosicarelli, B., Fagnani, C., & Aloisi, F. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1049-5 · Cited by 84
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Christensen, J. R., Börnsen, L. S., Hesse, D., Krakauer, M., Sørensen, P. S., Søndergaard, H. B., & Sellebjerg, F. T. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-215 · Cited by 86
The peripheral immune response after stroke—A double edge sword for blood‐brain barrier integrity
Li, Y., Zhu, Z., Huang, T., Zhou, Y., Wang, X., Yang, L., Chen, Z., Yu, W., & Li, P. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13081 · Cited by 84
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients
Serpero, L. D., Filaci, G., Parodi, A., Battaglia, F., Kalli, F., Brogi, D., Mancardi, G., Uccelli, A., & Fenoglio, D. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9465-5 · Cited by 82
Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses
Paroni, M., Maltese, V., De Simone, M., Ranzani, V., Larghi, P., Fenoglio, C., Pietroboni, A. M., De Riz, M. A., Crosti, M. C., Maglie, S., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.11.045 · Cited by 77
CCR2+CCR5+ T Cells Produce Matrix Metalloproteinase-9 and Osteopontin in the Pathogenesis of Multiple Sclerosis
Sato, W., Katsumoto, A., Ichikawa, D., Lin, Y., Kishida, H., Miyake, S., Ogawa, M., Okamoto, T., Murata, M., Kuroiwa, Y., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202026 · Cited by 80
PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation
Linnerbauer, M., Beyer, T., Nirschl, L., Farrenkopf, D., Lößlein, L., Vandrey, O., Peter, A., Tsaktanis, T., Kébir, H., Laplaud, D. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40982-8 · Cited by 83
Self-citation
The good and the bad of neuroinflammation in multiple sclerosis
Naegele, M., & Martinꝉ, R. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00003-0 · Cited by 85
SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function
Ahmed, C. M. I., Larkin, J., & Johnson, H. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00183 · Cited by 82
Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis
Darlington, P. J., Boivin, M., Renoux, C., François, M., Galipeau, J., Freedman, M. S., Atkins, H. L., Cohen, J. A., Solchaga, L. A., & Bar‐Or, A. (2010) · Annals of Neurology · doi:10.1002/ana.22065 · Cited by 80
Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity
Contreras, F., Prado, C. E., González, H., Demane, D. F., Osorio‐Barrios, F., Osorio, F., Ugalde, V., López, E., Elgueta, D., Figueroa, A., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502420 · Cited by 80
A gradient of glucocorticoid sensitivity among helper T cell cytokines
Banuelos, J., & Lu, N. (2016) · Cytokine & growth factor reviews · doi:10.1016/j.cytogfr.2016.05.002 · Cited by 70
A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells
McMurchy, A. N., Gillies, J., Gizzi, M. C., Riba, M., Garcia-Manteiga, J. M., Cittaro, D., Lazarevic, D., Di Nunzio, S., Piras, I. S., Bulfone, A., et al. (2013) · Blood · doi:10.1182/blood-2012-05-431023 · Cited by 77
CCR6+ Th cells in the cerebrospinal fluid of persons with multiple sclerosis are dominated by pathogenic non-classic Th1 cells and GM-CSF-only-secreting Th cells
Restorick, S. M., Durant, L., Kalra, S., Hassan‐Smith, G., Rathbone, E. J., Douglas, M. R., & Curnow, J. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.03.008 · Cited by 82
Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis
Darlington, P. J., Stopnicki, B., Touil, T., Doucet, J.-S., Fawaz, L. M., Roberts, M. E., Boivin, M., Arbour, N., Freedman, M. S., Atkins, H. L., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00834 · Cited by 79
Self-citation
IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses
Chong, W. P., Horai, R., Mattapallil, M. J., Silver, P. B., Chen, J., Zhou, R., Sergeev, Y. V., Villasmil, R., Chan, C., & Caspi, R. R. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.08.003 · Cited by 81
Alemtuzumab long-term immunologic effect
Mercanti, S. F. D., Rolla, S., Cucci, A., Bardina, V., Cocco, E. E., Vladić, A., Soldo-Butković, S., Habek, M., Adamec, I., Horáková, D., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000194 · Cited by 79
Emerging aspects of cytokine storm in COVID-19: The role of proinflammatory cytokines and therapeutic prospects
Dharra, R., Sharma, A. K., & Datta, S. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156287 · Cited by 82
Identity crisis of Th17 cells: many forms, many functions, many questions
Sundrud, M. S., & Trivigno, C. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.021 · Cited by 77
T-helper cell diversity in experimental autoimmune encephalomyelitis and Multiple Sclerosis
Carbajal, K. S., Mironova, Y. A., Ulrich-Lewis, J. T., Kulkarni, D., Grifka-Walk, H. M., Huber, A. K., Shrager, P., Giger, R., & Segal, B. (2015) · Journal of Immunology · doi:10.4049/jimmunol.1501097 · Cited by 72
B Cell-Derived IL-15 Enhances CD8 T Cell Cytotoxicity and Is Increased in Multiple Sclerosis Patients
Schneider, R., Mohebiany, A. N., Ifergan, I., Beauseigle, D., Duquette, P., Prat, A., & Arbour, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100885 · Cited by 76
Self-citation
Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation
Karnell, F. G., Lin, D. Y., Motley, S., Duhen, T., Lim, N., Campbell, D., Turka, L. A., Maecker, H. T., & Harris, K. M. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12985 · Cited by 75
miR26a Modulates Th17/Treg Balance in the EAE Model of Multiple Sclerosis by Targeting IL6
Zhang, R., Tian, A., Wang, J., Shen, X., Qi, G., & Tang, Y. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8335-5 · Cited by 76
Production of IL ‐27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses
Sénécal, V., Deblois, G., Beauseigle, D., Schneider, R., Brandenburg, J., Newcombe, J., Moore, C. S., Prat, A., Antel, J. P., & Arbour, N. (2015) · Glia · doi:10.1002/glia.22948 · Cited by 74
Self-citation
Melanoma cell adhesion molecule–positive CD 8 T lymphocytes mediate central nervous system inflammation
Larochelle, C., Lécuyer, M., Alvarez, J. I., Charabati, M., Saint‐Laurent, O., Ghannam, S., Kébir, H., Flanagan, K., Yednock, T. A., Duquette, P., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24415 · Cited by 80
Self-citation
Th17 cell pathogenicity in autoimmune disease
Park, E., & Ciofani, M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01535-9 · Cited by 75
Participation of interleukin 17A in neuroimmune interactions
Moynes, D. M., Vanner, S. J., & Lomax, A. E. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.03.004 · Cited by 70
Discovery of [cis-3-({(5R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist
Kono, M., Ochida, A., Oda, T., Imada, T., Banno, Y., Taya, N., Masada, S., Kawamoto, T., Yonemori, K., Nara, Y., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00061 · Cited by 72
Targeting Nrf2/HO-1 anti-oxidant signaling pathway in the progression of multiple sclerosis and influences on neurological dysfunctions
Upadhayay, S., & Mehan, S. (2021) · Brain Disorders · doi:10.1016/j.dscb.2021.100019 · Cited by 72
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS
Huber, A. K., Wang, L., Han, P., Zhang, X., EKHOLM, S. E., Srinivasan, A., Irani, D. N., & Segal, B. M. (2014) · Neurology · doi:10.1212/wnl.0000000000000908 · Cited by 69
The Enigmatic Role of Viruses in Multiple Sclerosis: Molecular Mimicry or Disturbed Immune Surveillance?
Geginat, J., Paroni, M., Pagani, M., Galimberti, D., Francesco, R. D., Scarpini, E. A., & Abrignani, S. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.04.006 · Cited by 73
Dietary naringenin supplementation attenuates experimental autoimmune encephalomyelitis by modulating autoimmune inflammatory responses in mice
Wang, J., Qi, Y., Niu, X., Tang, H., Meydani, S. N., & Wu, D. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.12.004 · Cited by 70
The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis
Jager, L. D., Dabelic, R., Waiboci, L. W., Lau, K., Haider, M. S., Ahmed, C. M. I., Larkin, J., David, S., & Johnson, H. M. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.018 · Cited by 68
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation
Sosa, R. A., Murphey, C. L., Robinson, R. R., & Forsthuber, T. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505955112 · Cited by 70
Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators
Alvarenga-Filho, H., Sacramento, P. M., Ferreira, T. B., Hygino, J., Abreu, J. E. C., de Carvalho, S. R. D. S., Wing, A. C., Alvarenga, R. M. P., & Bento, C. A. M. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.02.014 · Cited by 68
Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis
Herich, S., Schneider‐Hohendorf, T., Rohlmann, A., Ghadiri, M. K., Schulte‐Mecklenbeck, A., Zondler, L., Janoschka, C., Ostkamp, P., Richter, J., Breuer, J., et al. (2019) · Brain · doi:10.1093/brain/awz301 · Cited by 67
Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability
Kallaur, A. P., Oliveira, S. R., Simão, A. N. C., Alfieri, D. F., Flauzino, T., Lopes, J., de Carvalho Jennings Pereira, W. L., de Meleck Proença, C., Borelli, S. D., Kaimen-Maciel, D. R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9846-x · Cited by 75
Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammation
Larochelle, C., Wasser, B., Jamann, H., Löffel, J. T., Cui, Q., Tastet, O., Schillner, M., Luchtman, D. W., Birkenstock, J., Stroh, A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025813118 · Cited by 72
Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers
Michel, L., Grasmuck, C., Charabati, M., Lécuyer, M., Zandee, S., Dhaeze, T., Alvarez, J. I., Li, R., Larouche, S., Bourbonnière, L., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw0475 · Cited by 72
Self-citation
Gut inflammation promotes microbiota-specific CD4 T cell-mediated neuroinflammation
White, Z., Cabrera, I., Mei, L., Clevenger, M. H., Ochoa-Raya, A., Kapustka, I., Dominguez, J. R., Zhou, J., Koster, K. P., Anwar, S., et al. (2025) · Nature · doi:10.1038/s41586-025-09120-w · Cited by 72
Disruption of the blood–brain barrier in 22q11.2 deletion syndrome
Crockett, A. M., Ryan, S. K., Vásquez, A. H., Canning, C., Kanyuch, N., Kébir, H., Ceja, G., Gesualdi, J., Zackai, E. H., McDonald‐McGinn, D. M., et al. (2021) · Brain · doi:10.1093/brain/awab055 · Cited by 62
Self-citation
Circulating immune cells in multiple sclerosis
Jones, A. P., Kermode, A. G., Lucas, R. M., Carroll, W. M., Nolan, D. A., & Hart, P. H. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12878 · Cited by 65
Down-regulation of taurine-up-regulated gene 1 attenuates inflammation by sponging miR-9-5p via targeting NF-κB1/p50 in multiple sclerosis
Yue, P., Jing, L., Zhao, X., Zhu, H., & Teng, J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116731 · Cited by 65
Functional characteristics of Th1, Th17, and ex-Th17 cells in EAE revealed by intravital two-photon microscopy
Loos, J., Schmaul, S., Noll, T. M., Paterka, M., Schillner, M., Löffel, J. T., Zipp, F., & Bittner, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02021-x · Cited by 71
The Ins and Outs of Central Nervous System Inflammation—Lessons Learned from Multiple Sclerosis
Ramaglia, V., Rojas, O. L., Naouar, I., & Gommerman, J. L. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-124155 · Cited by 72
An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells
Hwang, I., Ahn, G., Park, E., Ha, D., Song, J., & Jee, Y. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.04.005 · Cited by 64
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal
Larochelle, C., Metz, I., Lécuyer, M., Terouz, S., Roger, M., Arbour, N., Brück, W., & Prat, A. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516641775 · Cited by 64
Self-citation
CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis
Dhaeze, T., Tremblay, L., Lachance, C., Peelen, E., Zandee, S., Grasmuck, C., Bourbonnière, L., Larouche, S., Ayrignac, X., Rébillard, R., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0198-5 · Cited by 63
Self-citation
Lack of the T cell–specific alternative p38 activation pathway reduces autoimmunity and inflammation
Jirmanova, L., Torchia, M. L. G., Sarma, N. D., Mittelstadt, P. R., & Ashwell, J. D. (2011) · Blood · doi:10.1182/blood-2011-01-333039 · Cited by 62
Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy
Wilde, B., Thewissen, M., Damoiseaux, J., Hilhorst, M., van Paassen, P., Witzke, O., & Tervaert, J. C. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4066 · Cited by 68
Network-based analysis of differentially expressed genes in cerebrospinal fluid (CSF) and blood reveals new candidate genes for multiple sclerosis
Safari‐Alighiarloo, N., Rezaei–Tavirani, M., Taghizadeh, M. T., Tabatabaei, S. M., & Namaki, S. (2016) · PeerJ · doi:10.7717/peerj.2775 · Cited by 54
Th17/Th1 phenotype in demyelinating disease
Edwards, L. J., Robins, R. A., & Constantinescu, C. S. (2010) · Cytokine · doi:10.1016/j.cyto.2009.12.003 · Cited by 59
Vitamin D modulates different IL-17-secreting T cell subsets in multiple sclerosis patients
da Costa, D. S. M. M., Hygino, J., Ferreira, T. B., Kasahara, T. M., Barros, P. O., Monteiro, C., de Oliveira, A. L., Tavares, F., Vasconcelos, C. C. F., Alvarenga, R. M. P., et al. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.08.005 · Cited by 58
Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges
Khan, Z., Gupta, G. D., & Mehan, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134274 · Cited by 59
TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
Byström, J., Clanchy, F. I. L., Taher, T. E. I., Mangat, P. K., Jawad, A. S., Williams, R. O., & Mageed, R. A. (2016) · Cytokine · doi:10.1016/j.cyto.2016.09.001 · Cited by 58
Long‐term peripheral immune cell profiling reveals further targets of oral cladribine in MS
Moser, T., Schwenker, K., Seiberl, M., Feige, J., Akgün, K., Haschke‐Becher, E., Ziemssen, T., & Sellner, J. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51206 · Cited by 56
The chromatin landscape of Th17 cells reveals mechanisms of diversification of regulatory and pro-inflammatory states
Thakore, P. I., Schnell, A., Zhao, M., Huang, L., Hou, Y., Christian, E., Zaghouani, S., Wang, C., Singh, V., Ma, S., et al. (2022) · doi:10.1101/2022.02.26.482041 · Cited by 57
The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal Models
Segal, B. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010120 · Cited by 60
Immunopathology alters Th17 cell glucocorticoid sensitivity
Banuelos, J., Cao, Y., Shin, S. C., & Lu, N. Z. (2016) · Allergy · doi:10.1111/all.13051 · Cited by 56
Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis
Agrawal, S. M., Williamson, J., Sharma, R. S., Kébir, H., Patel, K. D., Prat, A., & Yong, V. W. (2013) · Brain · doi:10.1093/brain/awt093 · Cited by 55
Self-citation
The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis
Angelini, G., Bani, A., Constantin, G., & Rossi, B. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1101379 · Cited by 57
IL-21 Is a Central Memory T Cell–Associated Cytokine That Inhibits the Generation of Pathogenic Th1/17 Effector Cells
Kastirr, I., Maglie, S., Paroni, M., Alfen, J. S., Nizzoli, G., Sugliano, E., Crosti, M., Moro, M., Steckel, B., Steinfelder, S., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400775 · Cited by 57
Alpha2beta1 integrin is the major collagen‐binding integrin expressed on human Th17 cells
Boisvert, M., Chetoui, N., Gendron, S., & Aoudjit, F. (2010) · European Journal of Immunology · doi:10.1002/eji.201040307 · Cited by 53
Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers
Verreycken, J., Baeten, P., & Broux, B. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2153534 · Cited by 61
Targeting cytokine networks in neuroinflammatory diseases
Becher, B., Derfuss, T. J., & Liblau, R. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01026-y · Cited by 56
CD2 Costimulation Reveals Defective Activity by Human CD4+CD25hi Regulatory Cells in Patients with Multiple Sclerosis
Baecher‐Allan, C., Costantino, C. M., Cvetanovich, G. L., Ashley, C. W., Bériou, G., Dominguez‐Villar, M., & Hafler, D. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002502 · Cited by 53
Human Mesenchymal Stem Cells Upregulate CD1dhighCD5+ Regulatory B Cells in Experimental Autoimmune Encephalomyelitis
Guo, V. Y., Chan, K., Lai, W., Siu, C., Kwan, S.-C., Tse, H., Ho, P. W., & Ho, J. W.-M. (2013) · NeuroImmunoModulation · doi:10.1159/000351450 · Cited by 51
Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis
Pardo, E., Cárcamo, C., Martín, R. U., Ciampi, E., Segovia‐Miranda, F., Curkovic, C., Montecino, F., Holmes, C., Tichauer, J. E., Acuña, E., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177472 · Cited by 54
DICAM promotes T H 17 lymphocyte trafficking across the blood-brain barrier during autoimmune neuroinflammation
Charabati, M., Grasmuck, C., Ghannam, S., Bourbonnière, L., Fournier, A. P., Lécuyer, M., Tastet, O., Kébir, H., Rébillard, R., Hoornaert, C., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj0473 · Cited by 51
Self-citation
Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis
Benkert, T. F., Dietz, L., Hartmann, E., Leich, E., Rosenwald, A., Serfling, E., Buttmann, M., & Berberich‐Siebelt, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052208 · Cited by 51
Interleukin‐17‐ and interleukin‐22‐secreting myelin‐specific CD 4+ T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients
Wing, A. C., Hygino, J., Ferreira, T. B., Kasahara, T. M., Barros, P. O., Sacramento, P. M., de Andrade, R. M., Camargo, S. M. D. G. G., Rueda, F., Alves‐Leon, S. V., et al. (2015) · Immunology · doi:10.1111/imm.12552 · Cited by 51
RORγt+ cells selectively express redundant cation channels linked to the Golgi apparatus
Drujont, L., Lemoine, A., Moreau, A., Bienvenu, G., Lancien, M., Cens, T., Guillot, F., Bériou, G., Bouchet‐Delbos, L., Fehling, H. J., et al. (2016) · Scientific Reports · doi:10.1038/srep23682 · Cited by 51
Targeting the GM-CSF receptor for the treatment of CNS autoimmunity
Ifergan, I., Davidson, T. S., Kébir, H., Xu, D., Palacios-Macapagal, D., Cann, J. A., Rodgers, J. M., Hunter, Z. N., Pittet, C. L., Beddow, S. A., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.06.005 · Cited by 55
Self-citation
In VitroMeasles Virus Infection of Human Lymphocyte Subsets Demonstrates High Susceptibility and Permissiveness of both Naive and Memory B Cells
Laksono, B. M., Großerichter-Wagener, C., de Vries, R. D., Langeveld, S. A. G., Brem, M. D., van Dongen, J. J. M., Katsikis, P. D., Koopmans, M., van Zelm, M. C., & de Swart, R. L. (2018) · Journal of Virology · doi:10.1128/jvi.00131-18 · Cited by 51
The Multifaceted Role of Th17 Lymphocytes and Their Associated Cytokines in Cancer
Alizadeh, D., Katsanis, E., & Larmonier, N. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/957878 · Cited by 55
Stage-Specific Immune Dysregulation in Multiple Sclerosis
Segal, B. M. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0025 · Cited by 49
Role of statins in the treatment of multiple sclerosis
Ciurleo, R., Bramanti, P., & Marino, S. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.03.004 · Cited by 52

Authors: Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., & Prat, A.
Affiliations: Hôpital Notre-Dame (CA)
Corresponding author: Prat, Alexandre
ORCID: Ifergan, Igal
Alvarez, Jorge Ivan
Poirier, Josée
Arbour, Nathalie
Duquette, Pierre
Prat, Alexandre
Venue: Annals of Neurology
Publisher: Wiley
Published: 2009-09
Volume: 66
Issue: 3
Pages: 390-402
ISSN: 0364-5134 (ISSN-L)
1531-8249
DOI: 10.1002/ana.21748
OpenAlex: W2127568644
Cited by: 551
References: 39
Citations by year: 2026: 13 · 2025: 17 · 2024: 20 · 2023: 36 · 2022: 34 · 2021: 38 · 2020: 27 · 2019: 35 · 2018: 34 · 2017: 40 · 2016: 37 · 2015: 47 · 2014: 42 · 2013: 36 · 2012: 29
FWCI: 22.07
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 35 d)
Locations: Annals of Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords: multiple sclerosis, experimental autoimmune encephalomyelitis, Th17 cells, interferon-gamma, IL-17, IL-23, blood-brain barrier, T-bet, memory T cells, relapsing multiple sclerosis
MeSH terms: Adult, Animals, Blood-Brain Barrier, Brain, Cell Migration Inhibition, Central Nervous System, Encephalomyelitis, Autoimmune, Experimental, Female, Humans, Interferon-gamma, Mice, Inbred C57BL, Middle Aged, Multiple Sclerosis, T-Lymphocytes, Th1 Cells, Th2 Cells, Interleukin-17, Multiple Sclerosis, Relapsing-Remitting, Mice, Interleukin-23, Cell Migration Assays, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Preferential recruitment of interferon‐γ–expressing T H 17 cells in multiple sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks